Profile
ABCM VRTX REGN VRNA ARGX ALNY
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 1.76K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABCM VRTX REGN VRNA ARGX ALNY
Quant Rating Score 4 4 1 4 3
Quant Rating Buy Buy Strong Sell Buy Neutral
Trading
ABCM VRTX REGN VRNA ARGX ALNY
Last Close $23.99 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $23.99 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $23.99 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABCM VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 0 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
ABCM VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 71.21 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM 0.45 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 0.76 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 0.8 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 93.62 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 73.44 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM 2.03 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM 27.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 7.04 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 1.56 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 195.05 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 31.98 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM 0.3 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM 0.01 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 45.81 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 19.94 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM 27.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM - 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM 40.46 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM 40.46 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ABCM VRTX REGN VRNA ARGX ALNY
Revenue $0.36B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0.27B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 74.79% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $0.04B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.01B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -0.04 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ABCM VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.1B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.33B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.73B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.22B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $1.06B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ABCM VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $-0.01B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $-0.03B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $0.03B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0.04B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.69
AARD Aardvark Therapeutics, Inc. Common Stock 12.14
ABCL AbCellera Biologics Inc. 3.111
ABEO Abeona Therapeutics Inc. 5.005
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0131
ABSI Absci Corporation 2.545
ABUS Arbutus Biopharma Corporation 3.99
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.925
ACAD ACADIA Pharmaceuticals Inc. 22.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.84
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.205
ACIU AC Immune SA 2.98
ACLX Arcellx, Inc. 68.55
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 172.59
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 48.835
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 84.7
MNA IQ Merger Arbitrage ETF 6.85 36.34
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 88.76
FPXI First Trust International Equity Opportunities ETF 0.45 67.29
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 45.04
MRGR ProShares Merger ETF 3.16608 44.765
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 32.89
VINEX Vanguard International Explorer Fund Investor Shares 0.22 21.96
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 86.79
VGHCX Vanguard Health Care Fund Investor Shares 0.36 205.85
BMED BlackRock Future Health ETF 1.68229 30.48
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 29.45
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 7.345
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 8.7175
DFIC Dimensional International Core Equity 2 ETF 0.00052105 37.83
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 8.684
CTRU ARK Transparency ETF 0.96 12.897
Unlock